70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors. (17th December 2018)

Record Type:: Journal Article
Title:: 70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors. (17th December 2018)
Main Title:: 70OA phase Ia/Ib trial of tislelizumab, an anti-PD-1 antibody (ab), in patients (pts) with advanced solid tumors
Authors:: Deva, S
Lee, J-S
Lin, C-C
Yen, C-J
Millward, M
Chao, Y
Keam, B
Jameson, M
Hou, M-M
Kang, Y-K
Markman, B
Lu, C-H
Rau, K-M
Lee, K-H
Horvath, L
Friedlander, M
Hill, A
Wu, J
Hou, J
Desai, J
Abstract:
Is Part Of:: Annals of oncology. Volume 29(2018)Supplement 10
Journal:: Annals of oncology
Issue:: Volume 29(2018)Supplement 10
Issue Display:: Volume 29, Issue 10 (2018)
Year:: 2018
Volume:: 29
Issue:: 10
Issue Sort Value:: 2018-0029-0010-0000
Page Start:
Page End:
Publication Date:: 2018-12-17
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdy487.042 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12263.xml